What's Going On With Bio-Path Holdings Stock?

Bio-Path Holdings, Inc. BPTH shares are rocketing higher Friday on heavy trading volume. Here's a look at what's going on:

What To Know:

Shares of BPTH are up over 90% on remarkably heavy volume Friday, and trading has been halted multiple times for volatility.

According to data from Benzinga Pro, more than 63.5 million shares have already been traded in the session, significantly above the stock's 100-day average volume of just over 700 thousand shares,

On Sept. 13, the company received a noncompliance notice regarding the Nasdaq minimum bid requirement because its price per share had fallen below the $1.00 minimum closing price over the prior 30 consecutive trading days. 

Bio-Path Holdings has until March 11, 2024, to regain compliance with the minimum bid price listing rule by achieving a closing bid price of at least $1.00 for a minimum of ten consecutive business days. 

Bio-Path Holdings, Inc. is a clinical stage, oncology-focused, RNAi nanoparticle drug development company engaged in systemic delivery of target-specific protein inhibition.

Related News: What's Going On With Jaguar Health Stock? 

BPTH Price Action: According to Benzinga Pro, Bio-Path Holdings shares are up 95% at 77 cents at the time of publication.

Image: Ri Butov from Pixabay